Immune-related adverse events with immune checkpoint inhibitors: Special reference to the effects on the lungs

Immune checkpoint inhibitors (ICIs) have emerged as evolutionary treatments for malignant diseases. Although ICIs can cause immune-related adverse events (irAEs) in various organs, precise timing after ICI initiation has been scarcely reported. Elucidating the effects of irAEs, such as time to onset...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Hirata, Aya, Saraya, Takeshi, Kobayashi, Fumi, Noda, Akinari, Aso, Kaori, Sakuma, Sho, Kurokawa, Nozomi, Inoue, Manami, Mikura, Sunao, Oda, Miku, Ishida, Manabu, Honda, Kojiro, Nakamoto, Keitaro, Tamura, Masaki, Takata, Saori, Ishii, Haruyuki, Takizawa, Hajime
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2021
Assuntos:
5700
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8036099/
https://ncbi.nlm.nih.gov/pubmed/33832093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000025275
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados